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1 H-NMR and 13 C-NMR spectra for all final compounds.
p. 20 A. Bioassay data for all new compounds.
A.1. Vibrio cholerae Agonism Bioassay.
Reporter strain MM920 (V. cholerae ΔcqsA ΔluxQ carrying pBB1 cosmid, which contains the V. harveyi luxCDABE luciferase operon) was used to assay agonist activity of each synthetic compound. This strain was grown in LB medium containing 10 µg/mL tetracycline at 30 o C for >16 hours and diluted 20-fold with the same medium. Two µL of each synthetic compound dissolved in DMSO in various concentrations was added to 200 µL of the diluted reporter strain in triplicate in a 96-well plate. Bioluminescence and OD 600 were measured in a PerkinElmer EnVision Multilabel Reader following 4-hour incubation at 30 o C with shaking. DMSO was used as the negative control.
A.1.1. Example of dose-response curves from bioassay and data extracted.
Above is an example of typical dose response curve highlighting the data that is represented in the Tables presented in the manuscript. Both of the above doseresponse curves were generated using GraphPad Prism 5 from the identical primary luminescence measurements.
The dose-response curve on the left displays error bars that represent the 95% confidence intervals for each of the luminescence measurements. The curve on the right displays the standard deviation of the data.
EC 50 values were calculated by Prism 5 using standard settings and are described in the Tables and text in the manuscript with the error representing the 95% confidence interval for the calculated EC 50 value.
The values for % response described in the Tables and text in the manuscript describe the maximal luminescence change for each of the analogs as a percent of EaCAI-1 or 18 (set at 100%). One of these molecules was included as a positive standard of activity for each of the assays. The error described within the tables represents the 95% confidence intervals for this data expressed as a percentage. While there is typically little variation in the maximal luminescence at saturation, there is some noise at low concentrations, compare for example the 95% confidence intervals for the points of low compound concentration and the points of high concentration on the left.
A.2. Complete Bioassay Data and 95% Confidence Intervals for all Compounds.
A.2.1. Tabulated bioassay data for the compounds in Table 1 . Unless otherwise noted, all reactions were performed in flame-dried glassware under an atmosphere of nitrogen or argon using dried reagents and solvents. All chemicals were purchased from commercial vendors and used without further purification. Anhydrous solvents were purchased from commercial vendors.
A.2.2. Tabulated bioassay data for the compounds in
Flash chromatography was performed using standard grade silica gel 60 230-400 mesh from SORBENT Technologies. Silica gel was loaded into glass columns as a slurry. Analytical thin-layer chromatography was carried out using Silica G TLC plates, 200 μm with UV 254 fluorescent indicator (SORBENT Technologies), and visualization was performed by staining and/or by absorbance of UV light.
NMR spectra were recorded using a Bruker Avance II (500 MHz for million (ppm) and were calibrated according to residual protonated solvent. Highresolution mass spectral analysis was performed using an Agilent 1200-series electrospray ionization -time-of-flight (ESI-TOF) mass spectrometer in the positive ESI mode.
B.2. Compound Synthesis.
(Z)-benzyl (1-(methoxy(methyl)amino)-1-oxobut-2-en-2-yl)carbamate, 3a. To a solution of (Z)-2-(benzyloxycarbonylamino)but-2-enoic acid [1] (800 mg, 3.4 mmol) in DMF (16.7 mL) at ambient temperature and was treated with HOBt (1.2 g, 9.17 mmol), HNMe(OMe)-HCl (814 mg, 8.3 mmol), EDC (2.4 g, 12.5 mmol), and Et 3 N (2.3 mL, 16.7 mmol) sequentially and the mixture was allowed to stir for 10h at ambient temperature. The crude mixture was filtered through a plug of celite and concentrated in vacuo. The resulting oil was purified by silica gel chromatography eluting with a gradient from hexanes to 60%EtOAc/hexanes. Fractions containing the desired product were combined and concentrated in vacuo to provide (Z)-benzyl (1-(methoxy(methyl)amino)-1-oxobut-2-en-2-yl)carbamate (100 mg, 11% (Z)-allyl (1-(methoxy(methyl)amino)-1-oxobut-2-en-2-yl)carbamate, 5a. To a solution of VGly-HCl [1] (284.9 mg, 2.07 mmol) was dissolved in dioxane/H 2 O (20 mL, 0.02M, 1:1 dioxane:H 2 O) and was treated with NaHCO 3 (348 mg, 4.14 mmol) and allyl chloroformate (240 µL, 2.28 mmol) sequentially at room temperature. The resulting mixture was stirred at room temperature for 24 h and was then concentrated in vacuo to a volume of ca. 10 mL. The resulting solution was acidified with 10% KHSO 4 to ~pH6.5, was extracted with DCM (3 x 50mL), dried over Na 2 SO 4 and concentrated to dryness. The resulting oil was dissolved in THF (20.7 mL) at ambient temperature and was treated with HOBt (839 mg, 6.21 mmol), HNMe(OMe)-HCl (232 mg, 2.38 mmol), EDC (456 mg, 2.38 mmol), and Et 3 N (1.4 mL, 10.35 mmol) sequentially and the mixture was allowed to stir overnight at ambient temperature. The crude mixture was filtered through a plug of celite and concentrated in vacuo. The resulting oil was purified by silica gel chromatography eluting with a gradient from hexanes to 60% EtOAc/hexanes. Fractions containing the desired product were combined and concentrated in tert-butyl (2-oxoundecyl)carbonate. Prepared using a modification of a reported procedure. [2] To a solution of tert-Butyl (2-(methoxy(methyl)amino)-2-oxoethyl)carbamate (500 mg, 2.29mmol) in THF (23 mL) at 0 o C was added nonyl-MgBr (1.0M in Et 2 O, 11.5 mL, 11.5 mmol) and the mixture was allowed to stir at 0 o C for 4 h. The mixture was quenched with sat. NH 4 Cl (50 mL), extract with Et 2 O (2 x 50 mL), dry over Na 2 SO 4 and concentrate in vacuo. The mixture was purified by silica gel chromatography (20% to 40% EtOAc/hexanes) to provide tert-butyl (2-oxoundecyl)carbonate as a clear colorless oil (510 mg, 78%). 
3-methyl-5-nonylisoxazol-4-amine, 15.
To a solution of acetaldehyde oxime (1 g, 16.9 mmol) in DMF (34 mL) at room temperature was added N-chloro succinimide (2.9 g, 21.9 mmol) and the mixture was allowed to stir for 3.5 h. The reaction was quenched with H 2 O (40 mL), extracted with EtOAc (3 x 40 mL), dried over MgSO 4 , filtered and concentrated in vacuo to yield Nhydroxyacetimidoyl chloride as a clear, colorless oil that was used without further purification. To tert-butyl (2-oxoundecyl)carbonate (510 mg, 1.78 mmol) in THF (3.6 mL) at - mmol) as a solution in THF (1.8 mL). The resulting mixture was allowed to warm slowly to room temperature and was stirred at room temperature overnight. The reaction was quenched with sat. NH 4 Cl (10 mL), extracted with Et 2 O (3 x 10 mL), dried over Na 2 SO 4 and concentrated in vacuo. The residue (300 mg) was dissolved in CH 2 Cl 2 (9.3 mL) and H 2 O (140 µL) at room temperature and was treated with TFA (700 µL, 9.25 mmol). The mixture was allowed to stir overnight, was concentrated to dryness and the residue was purified by silica gel chromatography (40% EtOAc/hexanes to 100% EtOAc) to yield 3-methyl-5-nonylisoxazol-4-amine as a yellow solid (48 mg, 12% over two steps). 
4-methyl-3-nonylisoxazol-5-amine, 16.
To a solution of decanal oxime [3] (2 g, 11.67 mmol) in CH 2 Cl 2 (58 mL) at room temperature was added benzyltrimethylammonium tetrachloroiodate (4.89 g, 11.67 mmol) and the mixture was allowed to stir for 1 h before dilution with Et 2 O (280 mL). The resulting precipitate was removed by filtration and the filtrate was concentrated to dryness to provide N-hydroxydecanimidoyl chloride which was used without further purification. To propionitrile (1.22 mL, 17.49 mmol) in THF (35 mL) at - The cooled solution is treated with the appropriate acid chloride (1.0 eq) as a solution in PhMe (1.0M) and the mixture is allowed to warm slowly to room temperature and stirred overnight. The reaction is quenched with sat. NH 4 Cl (double reaction volume), extracted with Et 2 O (3 x double reaction volume), dried over Na 2 SO 4 and concentrated in vacuo before purification by silica gel chromatography. Both regioisomers of the acylated pyrrole are readily accessible in this manner. The 3-acylated pyrrole analogs typically eluted after the 2-acylated analogs. -pyrrol-2-yl)decan-1-one, 17 . Prepared according to general procedure A to provide 1-(1H-pyrrol-2-yl)decan-1-one as an off-white solid (1.8 g, 28% -pyrrol-3-yl)decan-1-one, 18 . Prepared according to general procedure A to provide 1-(1H-pyrrol-2-yl)decan-1-one as an off-white solid (1.3 g, 20%) . -pyrrol-3-yl)heptan-1-one, 22 . Prepared according to general procedure A to provide 1-(1H-pyrrol-3-yl)heptan-1-one as an off-white solid (121 mg, 5% -pyrrol-3-yl)octan-1-one, 23 . Prepared according to general procedure A to provide 1-(1H-pyrrol-3-yl)octan-1-one as an off-white solid (92 mg, 33%). 
1-(1H

C. Western Blot Analysis.
Overnight cultures of V. cholerae CqsA-LuxQ-were diluted 1000-fold in AKI medium containing the indicated compounds. The cultures were grown under static conditions at 37 o C for 4h and then were shaken for 18h at 37 o C. Cells were collected by centrifugation, TcpA and HapR from different samples were analyzed by Western Blot as previously described. [4, 5] D. Murine 3T3 Fibroblast Cell Toxicity Assay.
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3T3 cells were prepared as described previously in a 24-well plate and incubated for 24h at 37 o C. [6] The culture media was replaced by media containing the compound 18 at the indicated concentrations and the plates were visually examined using a microscope for cytotoxicity after incubation in the presence of the compound for 24h. Representative images displaying the effects of different concentrations of 18 on 3T3 cells are provided below.
E. Cytotoxicity of 18 in V. cholerae as assessed by OD 600 .
Plot showing the no effect on growth of Vibrio cholerae strain MM920 under the conditions described for biological assay (Section A). Diamonds represent luminescence measurements in the presence of varying concentrations of compound 18. Circles represent the OD 600 at each of the concentrations of 18. 
